<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document SYSTEM "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP1003751A1" country="EP" dtd-version="ep-patent-document-v1-4.dtd" doc-number="1003751" date-publ="20000531" file="98939182.6" lang="en" kind="A1" status="n"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYAL</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360   - Ver 2.9 (30 Jun 1998) 1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1003751</B110><B130>A1</B130><B140><date>20000531</date></B140><B190>EP</B190></B100><B200><B210>98939182.6</B210><B220><date>19980804</date></B220><B240><B241><date>20000126</date></B241></B240><B250>En</B250><B251EP>En</B251EP><B260>En</B260></B200><B300><B310>54753 P</B310><B320><date>19970804</date></B320><B330><ctry>US</ctry></B330><B310>128512</B310><B320><date>19980803</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20000531</date><bnum>200022</bnum></B405><B430><date>20000531</date><bnum>200022</bnum></B430></B400><B500><B510><B516>7</B516><B511> 7C 07D 495/04   A</B511><B512> 7A 61K  31/44   B</B512><B512> 7A 61K  31/55   B</B512><B512> 7C 07D 491/048  B</B512><B512> 7C 07D 498/04   B</B512><B512> 7C 07D 513/04   B</B512><B514> 7C 07D 495/04   J</B514><B514> 7C 07D 333:00   J</B514><B514> 7C 07D 495/04   L</B514><B514> 7C 07D 333:00   L</B514><B514> 7C 07D 495/04   N</B514><B514> 7C 07D 333:00   N</B514><B515> 7C 07D 221:00   Z</B515><B515> 7C 07D 223:00   Z</B515><B515> 7C 07D 225:00   Z</B515><B517EP> // (C07D495/04, 333:00), C07D221:00,(C07D495/04, 333:00), C07D223:00,(C07D495/04, 333:00), C07D225:00</B517EP></B510><B540><B541>de</B541><B542>HYDROXAMSÄURE SUBSTITUIERTE KONDENSIERTE HETEROCYCLISCHE METALLOPROTEINASE INHIBITOREN</B542><B541>en</B541><B542>HYDROXAMIC ACID SUBSTITUTED FUSED HETEROCYCLIC METALLOPROTEINASE INHIBITORS</B542><B541>fr</B541><B542>INHIBITEURS DE METALLOPROTEASES HETEROCYCLIQUES HYBRIDES ET SUBSTITUES PAR DE L'ACIDE HYDROXAMIQUE</B542></B540></B500><B700><B710><B711><snm>AMGEN INC.</snm><iid>00923238</iid><irf>FB8837-E13975EP</irf><adr><str>Amgen Center,One Amgen Center Drive</str><city>Thousand Oaks, CA 91320-1789</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>THOMSON, David, S.</snm><adr><str>5377 Wild Dunes Court</str><city>Boulder, CO 80301</city><ctry>US</ctry></adr></B721><B721><snm>KOCH, Kevin</snm><adr><str>7227 Four Rives Road</str><city>Boulder, CO 80301</city><ctry>US</ctry></adr></B721><B721><snm>HWANG, Chan, Kou</snm><adr><str>4862 Fountain Street</str><city>Boulder, CO 80304</city><ctry>US</ctry></adr></B721><B721><snm>RUSSO-RODRIGUEZ, Sandra, E.</snm><adr><str>1527 East Riverbend Street</str><city>Superior, CO 80027</city><ctry>US</ctry></adr></B721><B721><snm>HUMMEL, Conrad</snm><adr><str>1767 West Barberry Circle</str><city>Louisville, CO 80027</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Richardson, Kate</snm><sfx>et al</sfx><iid>00080182</iid><adr><str>Forrester &amp; Boehmert,Franz-Joseph Strasse 38</str><city>80801 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20000126</date></B845EP><B845EP><ctry>LT</ctry><date>20000126</date></B845EP><B845EP><ctry>LV</ctry><date>20000126</date></B845EP><B845EP><ctry>MK</ctry><date>20000126</date></B845EP><B845EP><ctry>RO</ctry><date>20000126</date></B845EP><B845EP><ctry>SI</ctry><date>20000126</date></B845EP></B844EP><B860><B861><dnum><anum>US9816147</anum></dnum><date>19980804</date></B861><B862>En</B862></B860><B870><B871><dnum><pnum>WO9906410</pnum></dnum><date>19990211</date><bnum>199906</bnum></B871></B870></B800></SDOBI></ep-patent-document>
